Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective ...

Geron Corporation (NASDAQ:GERN) is one of the best low priced pharma stocks to buy now. Earlier on May 28, Geron Corporation ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

Dr. Mika Kontro, MD, PhD, will deliver a presentation titled "Efficacy of Macrophage Checkpoint Clever-1 Inhibition with ...

Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.

It took a misplaced elbow, a quirk of Los Angeles geography and some whistling from his wife to produce one of television’s most memorable melodies.

The report provides a detailed analysis of the current myelodysplastic syndrome marketed drugs and late-stage pipeline drugs.

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. Drug ...

Pune: A 70-year-old woman from Mumbai, misdiagnosed with myelodysplastic syndromes (MDS), a type of blood cancer specifically ...

What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran ...

Researchers at the German Cancer Research Center (DKFZ) have now developed a method that allows for the first time to ...

Researchers working on an incurable blood cancer can now use a new lab model, which could make testing potential new ...